SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$42.91
+0.02 (+0.05%)
As of Nov 14, 2:29 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +4.4% upside
Low Target $31.89
Average Target $44.79
High Target $48.55
Current Price $42.91
Current
$42.91
Target
$44.79
$31.89 $44.79 avg $48.55
Scenario Analysis
Bear Case
$31.89
-25.7%
Low target
Base Case
$44.79
+4.4%
Avg target
Bull Case
$48.55
+13.1%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$127.90
-66.5% from high
52-Week Low
$38.06
+12.7% from low
Target vs 52W High
$44.79
-65.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%